Rockwell Medical (RMTI) Other Working Capital Changes (2010 - 2026)
Rockwell Medical (RMTI) posted Other Working Capital Changes of -$306000.0 for Q1 2026, down 191.89% on a QoQ basis from $333000.0 in Q3 2025, and up 35.58% year-over-year from -$225698.8 in Q1 2025.
Rockwell Medical (RMTI) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Rockwell Medical's Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$306000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 35.58% year-over-year to -$306000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$306000.0 (down 142.86% YoY) and the FY2025 annual result came in at -$475000.0, down 932.61% from the prior year.
- Other Working Capital Changes was -$306000.0 for Q1 2026 at Rockwell Medical, down from $333000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.5 million in Q4 2022 and bottomed at -$4.5 million in Q2 2022.
- A 5-year average of -$69470.6 and a median of -$378000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 333.03% — and 2024, when it jumped 273.98%.
- Rockwell Medical's Other Working Capital Changes stood at -$2.4 million in 2022, then retreated by 13.65% to -$2.7 million in 2023, then jumped by 99.56% to -$12000.0 in 2024, then surged by 2875.0% to $333000.0 in 2025, then plunged by 191.89% to -$306000.0 in 2026.
- Business Quant data shows RMTI's Other Working Capital Changes at -$306000.0 in Q1 2026, $333000.0 in Q3 2025, and -$333000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -426,000.00 |
| Mar 31, 2026 | -426,000.00 |
| Mar 31, 2026 | -426,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Dec 31, 2025 | 78,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Jun 30, 2025 | -665,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Mar 31, 2025 | -378,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |